ArticleFrontiers in medicine2026
Association between predicted body composition and metabolic-associated fatty liver disease: a case-control study in a Chinese population.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Metabolic-associated fatty liver disease (MASLD) is a growing global health concern. Few studies have examined the independent associations of fat mass (FM) and lean body mass (LBM) with MASLD. This study investigated the associations of predicted FM, body fat percentage (BF%), LBM, and the FM-to-LBM ratio with MASLD risk in a physical examination population from China. Methods: This 1:1 age- and sex-matched case-control study included 1,683 MASLD patients and 1,683 controls. Predicted FM, BF%, LBM, and FM/LBM were calculated using equations derived from the National Health and Nutrition Examination Survey (NHANES). Conditional logistic regression was used to analyze associations between body composition indices and MASLD risk after adjusting for confounders. Results: Levels of BMI, blood pressure, blood lipids, fasting glucose, liver enzymes, and uric acid were significantly higher in the MASLD group (all Conclusion: Elevated levels of predicted FM, BF%, and FM/LBM were independently associated with increased MASLD risk, showing non-linear dose-response relationships. Higher predicted LBM was also associated with increased MASLD risk; however, this finding should be interpreted with caution. These associations were more pronounced in younger, non-obese, and normotensive individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.